THE 2025 HUMANS TO THE MOON & MARS SUMMIT
an Explore Mars Event
May 28-29, 2025
Jack Morton Auditorium,
The George Washington University
Washington D.C.
Vikas Soni
JivaJet Inc | Cofounder and CSO; GWU | Postdoctoral Associate
With a specialization in cold atmospheric plasma for therapeutic use, Dr. Soni bridges fundamental science with real-world clinical application. He leads JIVAMED’s device design and biological validation efforts, working toward FDA approvals and animal trials for non-invasive treatments of skin infections and wound care. He holds a PhD in plasma medicine and a master’s in biochemistry, cellular, and molecular biology. His interdisciplinary research focuses on the development of Cold Atmospheric Plasma (CAP) technologies for the non-invasive treatment of cancer, viral infections, and antibiotic-resistant bacteria. His research interests span plasma medicine, cancer biology, space medicine, and astrobiology. Dr. Soni has extensive experience in cancer research and has worked at both the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA). At the NIH, he contributed to studies on cancer gene regulation, while at the FDA, he led research on CAP treatment for multidrug-resistant pathogens such as MRSA and E. coli, as well as plasma-based decontamination of PPE and surfaces. His work has also explored CAP applications for inactivating viruses like influenza and SARS-CoV-2.